H-LLFGLALIEV-OH

Ref. 3D-PP48262

Product Information

• Name: H-LLFGLALIEV-OH

Description

Peptide H-LLFGLALIEV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LLFGLALIEV-OH include the following: Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2 W Ma, C Germeau, N Vigneron - journal of cancer, 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20038 Analysis of the Processing of Seven Human TA by Intermediate - 2012 - researchgate.nethttps://www.researchgate.net/profile/Nicolas-Parmentier/publication/230747744_Analysis_of_the_Processing_of_Seven_Human_Tumor_Antigens_by_Intermediate_Proteasomes/links/56f1353708aec9e096b31545/Analysis-of-the-Processing-of-Seven-Human-Tumor-Antigens-by-Intermediate-Proteasomes.pdf HLA-A2 M Schumacher, T Mutis, B Rodenko, H Ovaa - 2014 - researchgate.nethttps://www.researchgate.net/profile/Robbert-Spaapen/publication/267749463_Altered_Peptide_Ligands_Revisited_Vaccine_Design_through_Chemically_Modified_HLA-A2-Restricted_T_Cell_Epitopes/links/56f1182308aea9fd53a87ca2/Altered-Peptide-Ligands-Revisited-Vaccine-Design-through-Chemically-Modified-HLA-A2-Restricted-T-Cell-Epitopes.pdf Analysis of the processing of seven human tumor antigens by intermediate proteasomes B Guillaume, V Stroobant - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/189/7/3538/86340 MAGE-C2-specific TCRs combined with epigenetic drug-enhanced antigenicity yield robust and tumor-selective T cell responses A Kunert, M van Brakel - The Journal of , 2016 - journals.aai.orghttps://journals.aai.org/jimmunol/article/197/6/2541/106100

• Brand: Biosynth